SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NTEG- Bloodless Glucose Monitor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Darrin Vernier who wrote (122)5/14/1998 11:21:00 PM
From: DryHeat  Read Replies (1) of 176
 
Darrin, Here are my thoughts.

Big news

The key manufacturing line and its patents take Integ out of the one product wonder class of company. It may have other applications.

Accuracy improvement. I am not sure what 3% errors is in reference to. But it sounds good and I think most of the products on the market now have low glucose level errors of some sort.

They are doing a large study with a product that may be FDA submittable at this point.

They may time the next stock offering with 510K submission which will make for a higher offer price.

Little News

Reduction in force

To all the Integ employees past and present out there Thank You. You give us hope.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext